Europe Collagen Peptides Market

Europe Collagen Peptides Market Size

The Europe collagen peptides market size was calculated to be USD 0.63 billion in 2025 and is anticipated to be worth USD 1.69 billion by 2034, from USD 0.70 billion in 2026, growing at a CAGR of 11.66% during the forecast period.

Collagen peptides refer to hydrolyzed forms of collagen, typically derived from bovine, porcine, or marine sources, that are bioavailable, soluble, and functionally integrated into dietary supplements, functional foods, and clinical nutrition products. Unlike native collagen, these peptides consist of short amino acid chains, primarily glycine, proline, and hydroxyproline, that are readily absorbed in the human digestive tract to support connective tissue integrity, skin elasticity, joint mobility, and muscle maintenance. The European Food Safety Authority recognizes the safety of collagen peptides for consumption, leading to higher adoption rates in products tailored for mobility, joint health, and skin rejuvenation among older adults and active individuals. Research indicates that a significant portion of the European Union population now belongs to the elderly demographic, creating substantial demand for products that support healthy aging, specifically targeting joint and skin health. Furthermore, European policy encourages the sustainable utilization of animal by-products, such as hides and bones, to create high-value collagen products, strengthening the alignment between collagen manufacturing and circular economy goals. Collagen peptides have transitioned from niche cosmetic ingredients to mainstream nutritional components in beverages, bars, and medical foods, fueled by rising interest in clean-label protein alternatives.

MARKET DRIVERS

Aging Population Driving Demand for Joint and Skin Health Solutions

The region’s rapidly aging demographic is a primary driver for the Europe collagen peptides market. Older adults are seeking non-pharmaceutical approaches to maintain mobility and dermal integrity. The population in certain regions is experiencing a structural shift towards older age brackets. Natural production of skin and joint-related structural proteins is known to decrease over time. This biological change appears to correspond with an increase in consumer interest in external supplementation. Research indicates that consistent intake of specific protein peptides may contribute to improved joint comfort and enhanced skin hydration. Health-focused organizations are beginning to incorporate these supplements into recommendations for addressing age-related physical changes. Retail markets are adjusting to this pattern by highlighting the functional benefits of these supplements for specific wellness goals. This convergence of demographic pressure, clinical validation, and retail positioning ensures sustained and growing demand across Western and Central Europe.

Rise of Clean Label High Protein Functional Foods and Beverages

The integration of collagen peptides into everyday food and drink formats has accelerated due to their neutral taste, solubility, and high protein density without allergen concerns like dairy or soy, which further contributes to the expansion of the Europe collagen peptides market. Sales of high-protein functional foods continue to rise in Europe, with collagen peptides becoming a staple ingredient in new sports nutrition and wellness product launches. Unlike whey or pea protein, collagen offers a unique amino acid profile that supports structural health rather than just muscle synthesis, making it attractive for holistic wellness positioning. Major brands such as Nestlé and Unilever have reformulated ready-to-drink protein waters and breakfast bars to include collagen peptides sourced from certified European bovine hides. The European Commission’s Circular Economy Action Plan encourages the repurposing of meat processing by-products, driving industry initiatives to utilize bovine hides for sustainable material applications. Moreover, collagen peptides carry no E number and are exempt from novel food classification when derived from traditional sources, enabling seamless clean label claims. This alignment with consumer preferences for recognizable ingredients and sustainability narratives has propelled collagen from supplement aisles into mainstream grocery and convenience channels.

MARKET RESTRAINTS

Regulatory Ambiguity Around Health Claims Under the EFSA Framework

The European Food Safety Authority’s stringent stance on substantiating health claims, despite widespread consumer use, is restraining the growth of the European collagen peptides market. Regulatory frameworks increasingly restrict the use of specific health claims, requiring manufacturers to adopt more generalized language. Also, regulatory guidance prioritizes broad descriptions of physiological maintenance over claims of targeted physical improvements. Evidence requirements for establishing direct cause-and-effect relationships remain high, leading to the rejection of many specific functional claims. The inability to use explicit efficacy language often shifts marketing strategies toward educational content or implied benefits. Brand owners frequently opt for conservative packaging language to ensure alignment with prevailing compliance standards. Limited messaging options can impact the immediate persuasiveness of product labeling for consumers. The contrast with markets like the United States, where structure-function claims are more liberally interpreted, creates a competitive disadvantage for European innovators. Furthermore, the lengthy and costly process of submitting dossiers for claim approval deters small and medium enterprises from pursuing scientific validation. Strict regulatory stances from EFSA continue to hinder the market's ability to share clinical benefits with consumers until a more adaptive approach is taken.

Consumer Skepticism Toward Animal-Derived Ingredients and Religious Dietary Restrictions

Cultural, ethical, and religious considerations significantly limit collagen peptide adoption in certain European segments because of their predominant sourcing from bovine and porcine tissues, which in turn hinders the expansion of the Europe collagen peptides market. According to sources, a significant and growing segment of European consumers, particularly flexitarians, is reducing meat intake and favoring sustainable, upcycled animal by-products over conventional animal-derived proteins. Additionally, religious dietary laws pose barriers. Driven by a rising population, demand for certified halal collagen in Europe is high, yet inconsistencies in certification standards for animal-derived products, particularly bovine gelatin, create uncertainty for consumers. Similarly, Jewish communities adhere to kosher standards that few collagen suppliers meet. A substantial portion of consumers across major Western European markets expresses discomfort with ingredients sourced from industrial slaughtering processes, indicating a shift toward cleaner labeling and non-animal alternatives. Marine collagen, derived from fish processing waste, is gaining popularity as a high-value, sustainable alternative, though it remains a premium market segment limited by higher production costs compared to traditional collagen sources. These sociocultural headwinds constrain market penetration, particularly among younger urban demographics who prioritize plant-based and ethically transparent nutrition, forcing manufacturers to invest heavily in certification transparency and alternative sourcing despite technical and economic challenges.

MARKET OPPORTUNITIES

Expansion into Medical Nutrition and Clinical Applications

Collagen peptides are gaining traction in clinical and medical nutrition settings where evidence-based protein supplementation is critical for recovery and chronic disease management, and are providing new opportunities for the Europe collagen peptides market. According to the European Society for Clinical Nutrition and Metabolism, a significant portion of hospitalized patients in the EU experience protein-energy malnutrition, which negatively impacts recovery, impairs wound healing, and increases the risk of complications. Collagen’s high glycine content supports tissue repair and is increasingly included in oral nutritional supplements for post surgical and geriatric care. Recent nutritional guidance in Germany supports the use of specific, high-dose collagen peptides as part of clinical nutrition strategies to enhance the healing rate of pressure ulcers in elderly patients. Hospitals in the Netherlands and Sweden now routinely prescribe collagen-enriched medical foods for orthopedic rehabilitation protocols. Furthermore, the European Commission’s Horizon Europe program is funding research into the role of bioactive peptides to manage sarcopenia and osteoarthritis, driving the clinical validation of nutritional therapies for aging-related conditions. The high volume of surgeries in the EU presents a major opportunity for high-compliance, pharmaceutical-grade collagen peptides that deliver measurable clinical outcomes through institutional channels.

Development of Sustainable Marine and Bioengineered Collagen Alternatives

Innovation in alternative collagen sources offers a strategic opportunity to overcome ethical and supply constraints while appealing to eco-conscious consumers, which is expected to propel the expansion of the Europe collagen peptides market. Marine collagen derived from fish processing by-products, such as skins and scales, is gaining ground as the EU generates millions of metric tons of fish waste annually, according to sources. Companies like Rousselot and Gelita have launched certified marine collagen peptides with full traceability from MSC-approved fisheries, reducing reliance on terrestrial animals. Beyond extraction, advances in synthetic biology are enabling fermentation-derived recombinant human collagen, which eliminates animal sourcing. Despite current economic limitations, these alternatives support the EU’s sustainable material strategies and offer a foothold in high-end cosmetic and clinical sectors. The maturation of EFSA regulatory frameworks for new production techniques promises to reshape the industry's raw material foundation while simultaneously expanding its consumer appeal on ethical and environmental grounds.

MARKET CHALLENGES

Inconsistent Raw Material Supply Due to Animal Disease Outbreaks and Slaughterhouse Regulations

Disruptions in bovine and porcine raw material streams caused by animal health crises and tightening slaughterhouse oversight remain a challenge to the Europe collagen peptides market. Disease-related livestock losses in specific European regions have directly reduced the overall availability of porcine hides. Protocols aimed at ensuring food safety and controlling diseases require the exclusion of certain materials, which limits the usable yield of bovine hides. Updated regulatory requirements regarding traceability and testing for animal by-products have increased the compliance burden for processors. These combined factors, including environmental, regulatory, and supply chain disruptions, create volatility in market prices and uncertainty in material availability. Labor challenges, including workforce shortages, can lead to temporary closures of processing facilities, causing sudden surges in hide prices. Since a large share of European collagen peptides relies on terrestrial sources, as per industry data, this dependency exposes the market to biological and regulatory shocks that are difficult to hedge. Diversification into marine or bioengineered sources remains limited by scale and cost, leaving the sector structurally fragile in the face of zoonotic threats and policy shifts.

Limited Consumer Awareness of Different Collagen Types and Bioavailability Differences

Many European consumers remain unaware of the functional distinctions between collagen types, sources, and molecular weights. This inhibits the expansion of the European collagen peptides market, despite the growing popularity of the products. Recent European market observations indicate that a significant portion of collagen supplement consumers lacks in-depth knowledge regarding the specific animal source of their products. Furthermore, only a minority of users fully comprehend the technical significance of hydrolyzed formulations and peptide chain lengths. This knowledge gap leads to suboptimal usage, such as selecting type I marine collagen for joint support when type II bovine is more relevant, or skepticism when expected results are not achieved. Retailers often exacerbate confusion by using vague terms like “hydrolyzed collagen” without specifying source or target benefit. Unlike vitamins or omega-3s, collagen lacks standardized labeling norms under EU food law, allowing wide variation in concentration and purity. Educational initiatives by industry groups like the European Collagen Producers Association reach only niche audiences. Consumer trust and retention in the collagen market will remain erratic, hindering premiumization, absent mandatory disclosure of molecular weight/type and coordinated public messaging.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Source Insights

The cattle hide and bones segment dominated the Europe Collagen Peptides Market by accounting for a 58.5% share in 2025. The dominance of the cattle hide and bones segment is driven by the continent’s robust beef processing industry, which generates significant metric tons of bovine hides annually. These hides, classified as category three animal by-products under EU Regulation EC No 1069 2009, are legally mandated for valorization rather than disposal, aligning collagen production with circular economy mandates under the European Green Deal. Furthermore, bovine collagen yields high concentrations of type I and III peptides, which are clinically associated with skin elasticity and connective tissue repair, key consumer priorities. Major processors such as Gelita and Rousselot operate integrated facilities in Germany and France that directly source from certified slaughterhouses, ensuring traceability and compliance with EFSA safety standards. The consistency of bovine peptide molecular weight distribution also enables reliable functionality in both supplements and functional foods. Despite ethical and religious constraints in niche populations, the European collagen peptide market remains structurally dominated by bovine-derived products, driven by established supply chains, scale, and purity.

The poultry and fish segment is estimated to register the fastest CAGR of 9.7% between 2026 and 2034 due to rising demand for halal, kosher, and pescatarian-compliant alternatives amid growing religious and ethical consumerism. Substantial quantities of marine byproducts, specifically fish skins and scales, are being utilized as sustainable sources for collagen production. The market is seeing the introduction of certified fish scale-derived peptides, which are marketed for their bioavailability in skin health applications. Collagen derived from poultry byproducts is experiencing increased interest within the sports nutrition sector for its potential in supporting muscle recovery. Regulatory updates in certain regions have eased market entry for hydrolyzed fish collagen by acknowledging it as a traditional food product, reducing the need for pre-market authorization. The intersection of clean labels, circularity, and inclusivity is unlocking new premium, ethical consumer segments that terrestrial, land-based products had previously failed to reach.

By Application Insights

The nutritional products segment was the largest in the Europe collagen peptides market by holding a 64.7% share in 2025. The supremacy of the nutritional products segment is attributed to its alignment with targeted health positioning, where dosage purity and clinical backing are paramount. Collagen peptides are extensively used in powder, capsule, and ready-to-drink formulations marketed for joint mobility, skin rejuvenation, and sarcopenia prevention, areas with strong scientific validation. Oral nutritional supplements containing collagen peptides are increasingly utilized in geriatric care to support skin integrity, joint health, and tissue maintenance due to their ability to improve dermal collagen networks and reduce skin fragility in older adults. The regulatory environment further supports this channel; under EU food law, dietary supplements allow higher daily doses than conventional foods, enabling efficacious intake levels of 8 to 12 grams. Major pharmacy chains in France, Italy, and the Netherlands dedicate entire shelves to collagen-based nutraceuticals, often co-branded with dermatologists or orthopedic specialists, enhancing credibility. Additionally, e-commerce platforms have amplified reach. This convergence of clinical relevance, regulatory permissiveness, and direct-to-consumer marketing solidifies nutritional products as the core application pillar.

The beverages segment is anticipated to grow at a CAGR of 11.2% during the forecast period, owing to the seamless integration of collagen peptides into ready-to-drink formats, including protein waters, smoothies, and functional juices that cater to on-the-go wellness lifestyles. Unlike powders, beverages offer immediate consumption without preparation—a critical advantage for time-constrained urban consumers. The European market for collagen-fortified beverages has experienced a notable increase in new product launches, with specific countries leading in the development of clear, functional hydration options. Innovations in functional beverages are focused on creating protein-enhanced waters that maintain transparency while incorporating peptides. Advancements in ingredient processing, specifically regarding protein hydrolysis, have improved peptide solubility and stability in water-based applications. Techniques now allow for the production of lower molecular weight peptides that remain stable across various acidity levels, preventing sedimentation. Nestlé and Unilever have reformulated flagship brands like Resource and Horlicks to include bovine and marine collagen in liquid formats targeting elderly and active populations, respectively. Furthermore, the EU’s 2023 front-of-pack nutrition labeling initiative favors beverages with added protein and no sugar, categories where collagen excels. This single SKU merges hydration and health, transforming daily collagen intake into a seamless, modern routine.

REGIONAL ANALYSIS

Germany Collagen Peptides Market Analysis

Germany led the European collagen peptides market by accounting for a 22.4% share in 2025. The prominence of the German market is credited to its advanced nutraceutical industry, stringent quality standards, and high consumer awareness of evidence-based wellness. Many collagen peptide products found in German pharmacies are certified by independent bodies, which helps confirm their quality and consistency. Germany hosts major global collagen producers that supply both domestic and international markets. The prevalence of age-related joint conditions among older adults contributes to a steady interest in joint health products. The national healthcare system indirectly supports usage by reimbursing medical nutrition in post surgical rehabilitation protocols. Additionally, Germany’s strong engineering sector enables precision hydrolysis technologies that yield peptides with consistent molecular profiles, a key differentiator in clinical and cosmetic applications. This blend of scientific rigor, manufacturing excellence, and demographic need cements Germany’s role as Europe’s innovation and volume leader.

France Collagen Peptides Market Analysis

France followed closely in the Europe collagen peptides market by holding a share of 18.7% in 2025. The growth of the French market is driven by its dual strength in luxury cosmetics and clinical nutrition, where collagen peptides bridge beauty from within and dermal science. The French National Agency for Food Safety recognizes collagen as a safe ingredient in both supplements and functional foods, enabling cross-category innovation. A notable portion of newly launched premium oral beauty brands in the French market incorporates marine or bovine collagen peptides. These collagen products are frequently paired with vitamin C to enhance their formulation. The local agricultural sectors, particularly in beef and poultry, contribute to a consistent supply of raw materials. Efforts to valorize animal by-products are integrated into broader circular economy initiatives. Paris-based research institutes like INRAE have published pivotal studies on collagen bioavailability, influencing EU-wide scientific discourse. Moreover, French consumers exhibit a high willingness to pay for premium wellness products. This cultural affinity for integrated beauty, health, and scientific legitimacy sustains France’s dynamic and high-value market position.

United Kingdom Collagen Peptides Market Analysis

The United Kingdom occupies a significant share of the Europe collagen peptides market due to its digitally native wellness culture, where e-commerce, social media, and influencer marketing drive rapid product adoption. A significant portion of collagen peptide purchases occurs through e-commerce platforms and direct-to-consumer brands. The emphasis on proactive health measures has increased the acceptance of nutritional supplementation. Official guidance regarding healthy aging highlights the importance of sufficient protein intake. Collagen is frequently suggested by health professionals to assist with joint and skin health. Despite Brexit, the UK maintains alignment with EFSA on ingredient safety, facilitating the continued import of EU-manufactured peptides. London and Manchester have emerged as hubs for functional beverage startups with brands like Formulate and Remedy launching collagen-infused sparkling waters targeting fitness-conscious millennials. Additionally, the UK hosts Europe’s largest halal consumer base, spurring demand for certified bovine and marine sources. This fusion of digital agility, regulatory continuity, and diverse consumer needs makes the UK a fast-moving and trend-setting market.

Italy Collagen Peptides Market Analysis

Italy secures a noteworthy posit the Europe Collagen Peptides Market owing to its Mediterranean wellness tradition where beauty, nutrition, and longevity are culturally intertwined. The country is a major producer of bovine and porcine byproducts, with a substantial number of metric tons of hides processed annually, providing local feedstock for domestic manufacturers like Italgelatine. An aging population in Italy is driving sustained demand for anti-aging and mobility products, with pharmacies serving as a key distribution channel. Italian pharmacies widely stock specialized collagen brands, which often incorporate local ingredients like olive polyphenols or citrus bioflavonoids. The premium "Made in Italy" positioning is strengthening the nutricosmetics market, driving increased exports of collagen-based products to Germany and France. For more details, visit the Italian National Institute of Statistics website. Furthermore, Italy’s strong dairy sector enables innovative integration into yogurts and fermented drinks, a format gaining traction among middle-aged women. This blend of heritage craftsmanship, demographic pressure, and cross-category innovation ensures Italy remains a high-engagement and culturally resonant market.

Spain Collagen Peptides Market Analysis

Spain is predicted to expand in the Europe collagen peptides market from 2026 to 2034 due to its expanding aquaculture industry and growing focus on active aging. The country is the EU’s second-largest producer of farmed fish, generating significant metric tons of salmon and sea bass annually, whose skins are increasingly diverted to marine collagen extraction as per the Spanish Ministry of Agriculture. Coastal regions like Galicia and Andalusia host specialized biorefineries converting fish waste into high-purity peptides for export and domestic use. At the same time, Spain’s aging population fuels demand for joint and bone health products, particularly in retirement communities along the Costa del Sol. Retail channels reflect this duality; supermarkets like Mercadona and Carrefour now offer private-label collagen powders alongside premium marine brands in pharmacy sections. The government’s 2023 National Strategy for Healthy Aging includes protein supplementation as a pillar, further legitimizingits usage. Spain is shifting from the European periphery to a central, strategic market, propelled by robust retail, demographic, and marine-related sectors.

COMPETITION OVERVIEW

The Europe Collagen Peptides Market features intense competition centered on scientific credibility, regulatory compliance, and raw material sustainability rather than price alone. While large integrated players like Gelita and Rousselot dominate through scale vertical integration and clinical validation, smaller specialized firms differentiate via niche sourcing, such as marine or organic collagen. Competition is further shaped by the European Food Safety Authority’s restrictive stance on health claims, which favors companies with robust dossier capabilities and long-term research partnerships. Brand owners increasingly evaluate suppliers based on transparency of origin, molecular weight consistency, and compatibility with clean label positioning. The market is also witnessing convergence with adjacent sectors, including medical nutrition, cosmetics, and sports performance, creating cross-industry rivalry for premium positioning. Despite entry barriers related to certification and hydrolysis technology innovation in fermentation-derived and upcycled sources is attracting biotech startups supported by EU Horizon funding. Ultimately, competitive advantage lies in the ability to deliver peptides that are not only bioactive but also ethically sourced, scientifically substantiated, and seamlessly integrable into diverse consumer formats.

KEY MARKET PLAYERS

A few major players of the Europe collagen peptides market include

• Cargill
• GELITA AG
• Rousselot
• Roxlor LLC
• InterHealth Nutraceuticals
• ItalgelatineSpA
• Kewpie Corporation
• LapiGelatine
• HolistaColltech Limited
• Gelnex
• Danish Crown A/S
• Weishardt Group
• Tessenderlo Group

Top Strategies Used by the Key Market Participants

Key players in the Europe Collagen Peptides Market are investing heavily in clinical research to generate EFSA-compliant evidence supporting specific health benefits. They are diversifying raw material sources by expanding marine and poultry-based collagen production to address ethical, religious, and sustainability concerns. Companies are enhancing traceability and certification, including halal, kosher, and non-GMO labels, to broaden consumer acceptance. Strategic partnerships with supplement food and beverage brands enable the co-development of application-specific peptide formulations. Additionally, firms are adopting circular economy practices by utilizing animal by-products from EU-regulated slaughterhouses, aligning with Farm to Fork and Green Deal objectives while securing stable feedstock supply.

Leading Players in the Europe Collagen Peptides Market

• Gelita AG is a German-headquartered global leader in collagen and gelatin solutions with deep integration across the European collagen peptides market. The company supplies high-purity bioactive peptides derived from bovine, porcine, and marine sources to the nutraceutical food and clinical nutrition sectors. Gelita’s R&D center in Eberbach focuses on tailoring peptide profiles for specific health outcomes such as joint mobility, skin elasticity, and muscle maintenance. In recent years, the company has strengthened its sustainability credentials by achieving full traceability from EU-certified slaughterhouses and obtaining halal and kosher certifications for key product lines. It also launched a digital platform providing clinical study summaries to brand partners, enabling science-backed marketing compliant with EFSA guidelines. These initiatives reinforce Gelita’s position as a trusted B2B innovator aligned with European regulatory and consumer expectations.
• Rousselot, a subsidiary of Darling Ingredients, operates as a major global supplier of collagen peptides with significant production and innovation capacity in Europe. Its Belgian and Dutch facilities produce Peptan-branded peptides widely used in functional food and beverage, and dietary supplements across the region. Rousselot emphasizes scientific validation, collaborating with universities in France and the Netherlands to publish peer-reviewed studies on collagen bioavailability and efficacy. Recently, the company expanded its marine collagen line using fish by-products sourced from MSC-certified fisheries, aligning with EU circular economy principles. It also introduced clean-label, compliant peptides with no additives or preservatives, meeting the rising demand for transparent ingredient lists. Through these actions, Rousselot bridges industrial scale with nutritional science, reinforcing its role as a strategic partner for premium wellness brands.
• Tessenderlo Group, a Belgian specialty ingredients company, plays a pivotal role in the European collagen peptides landscape through its Biosecto division, which focuses on sustainable protein solutions. The company leverages its expertise in amino acid chemistry to produce highly hydrolyzed collagen peptides optimized for solubility and stability in acidic beverage formats. Tessenderlo sources raw materials from EU-approved meat processing streams, ensuring compliance with animal by-product regulations. In 2023, it invested in a closed-loop water recycling system at its Ghent facility, reducing environmental impact while maintaining high purity standards. The company also partners with sports nutrition brands to develop peptides targeting muscle recovery and connective tissue support. Tessenderlo leverages green production techniques and bespoke formulations to meet the rising demand in active aging and functional hydration sectors.

MARKET SEGMENTATION

This research report on the Europe collagen peptides market has been segmented and sub-segmented based on source, application, and region.

By Source

• Pigskin
• Cattle Hide & Bones
• Poultry & Fish

By Application

• Nutritional Products
• Snacks & Cereals, Beverages
• Dairy Products
• Meat & Poultry Products

By Region

• UK
• France
• Spain
• Germany
• Ital
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe